Session Type
Meeting
Search Results for Opioid use disorder
Abstract Number: 344
SHM Converge 2023
Background: America is facing an opioid epidemic. From 1997 to 2017 there were 702,000 deaths from drug overdoses of which greater than 50% were from opioids. The opioid epidemic knows no boundaries, it affects men and women of all age groups and socioeconomic status. Hospitalists are now seeing more opioid related hospital admissions which have […]
Abstract Number: 358
SHM Converge 2023
Background: The incidence of Opioid Use Disorder (OUD) is rising around the world with nearly 27 million people living with OUD globally and over 100,000 opioid overdose deaths each year. The Society of Hospital Medicine recently released a consensus statement for management of patients with OUD admitted to the hospital. This statement included recommendations for […]
Abstract Number: 398
SHM Converge 2024
Background: Approximately 12% of hospitalizations are related to substance use disorder (SUD), an estimated 20% of hospitalized patients may have SUD, and patients with SUDs are nearly twice as likely to be readmitted. Pharmacotherapies for SUD are underutilized in hospitals, especially in Texas, due to lack of training, structures, and organizational cultures to support evidence-based […]
Abstract Number: 412
Hospital Medicine 2020, Virtual Competition
Background: Opioid use disorder (OUD) is a highly prevalent medical condition that is associated with significant morbidity and mortality. As rates of opioid addiction have increased in the last several years, hospitalists are uniquely positioned at the front lines to initiate evidence-based treatment for patients who are admitted with comorbid OUD and help link patients […]
Abstract Number: 422
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Drug overdose deaths are increasing throughout the country. Increasing naloxone availability is a cost-effective way to prevent opioid-related deaths. High-risk patients admitted in the hospital may benefit from a take-home naloxone prescription. This study aims to assess naloxone prescribing practices upon hospital discharge. Methods: An anonymous survey was distributed to attendings, residents, and advanced […]
Abstract Number: 695
SHM Converge 2021
Case Presentation: AS is 36-year-old woman with methamphetamine and opioid use disorder (OUD) hospitalized with endocarditis who is evaluated by the Addiction Consult Service (ACS), and started on sublingual Buprenorphine/naloxone (Bup/nx) for treatment of OUD. Urine drug screens continue to be inappropriately positive for methamphetamine inpatient. Extended Release Buprenorphine (Bup-XR) is discussed and with her […]
Abstract Number: 812
SHM Converge 2023
Case Presentation: A 34-year-old male with a history of opioid use disorder (OUD) was admitted after being found down secondary to heroin overdose. He was given 4 mg naloxone in the field with improvement in Glasgow Coma Score from 3 to 12. After naloxone administration, he was tachycardic, tachypneic, hypertensive, and agitated. He reported taking […]
Abstract Number: D12
SHM Converge 2022
Background: Neonatal abstinence syndrome (NAS) occurs when a neonate is exposed to licit or illicit chemical substances in utero and manifests withdrawal symptoms postnatally. Appropriate identification, documentation, and communication of NAS diagnosis is needed to qualify for federally funded therapies aimed at supporting development through early intervention (EI) programs. Our objective was to assess characteristics […]
Abstract Number: M29
SHM Converge 2022
Case Presentation: Central Adrenal Insufficiency (CAI) is a rare and often late diagnosis due to nonspecific signs, such as fatigue, hyponatremia, electrolyte abnormalities and fever of unknown origin (FUO). CAI suspicion arises in patients with pituitary tumors, cranial irradiation, surgery, injury, infection, exogenous glucocorticoid withdrawal, and less commonly known, opioid use disorder. A 31-year-old male […]
Oral Presentations
Abstract Number: Oral
SHM Converge 2021
Background: Despite evidence that the use of medications for patients with opioid use disorder (OUD) leads to reduced mortality and improved engagement in outpatient addiction treatment, these life-saving medications are underutilized in the hospital setting. This study reports the outcomes of a hospitalist-led interprofessional and multidisciplinary inpatient program, known as the B-Team (buprenorphine team), to […]